United States · 
Who invested in Hexagon Bio?
Hexagon Bio's investors include 8VC, SoftBank, SoftBank Vision Fund, Two Sigma Ventures and Casdin Capital, and 1 more on record.
United States · Series B startup
Who invested in Hexagon Bio
Funding summaryUpdated 26 Oct 2026
$77Mraised across 1 round since 2022, from 1 source
- Latest round
- Series B, $77MOct 2022
- Investors
- 6
The rounds
- Oct 2022Series B$77M
Source recordedSEC filing: $67M sold, first sale Sept 2022
Founders and team
From Hexagon Bio's own website and the SEC filings it signed: 3 on the team.
- Scott GarlandChairman
- Brian T NaughtonExecutive Officer, Directori
- Maureen E HillenmeyerExecutive Officer, Directori
On the board, as filediDavid T GoeddelJakob T LovenJuan T JaenMridula T Ray
Everyone who backed them
SoftBank Vision FundVC firm1round
CPP InvestmentsGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list Hexagon Bio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Trancos VenturesVC firmPer its own site
Quick answers about Hexagon Bio
How much has Hexagon Bio raised?
Hexagon Bio has raised $77M across 1 round since 2022.
When did Hexagon Bio last raise?
Hexagon Bio's most recent round was a Series B of $77M in Oct 2022.
What was Hexagon Bio's biggest round?
Its most recent round, $77M in Oct 2022, is also its largest on record.
Who backed Hexagon Bio first?
Hexagon Bio's first round on record, in Oct 2022, was backed by 8VC, SoftBank and SoftBank Vision Fund and 3 others.
What stage is Hexagon Bio at?
Hexagon Bio's latest named round is a Series B, in Oct 2022.
Where is Hexagon Bio based?
Hexagon Bio is based in the United States.
Companies like Hexagon Bio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.